KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $1,406,682 | $846,526 | $1,191,784 | $1,081,819 |
| - Cash | $175,424 | $201,214 | $237,595 | $54,352 |
| + Debt | $2,927 | $3,103 | $44,311 | $46,611 |
| Enterprise Value | $1,234,185 | $648,415 | $998,500 | $1,074,078 |
| Revenue | $22,565 | $19,371 | $17,233 | $15,090 |
| % Growth | 16.5% | 12.4% | 14.2% | – |
| Gross Profit | $11,424 | $8,851 | $7,633 | $6,547 |
| % Margin | 50.6% | 45.7% | 44.3% | 43.4% |
| EBITDA | -$28,477 | -$21,853 | -$47,413 | -$18,070 |
| % Margin | -126.2% | -112.8% | -275.1% | -119.7% |
| Net Income | -$32,785 | -$25,826 | -$52,053 | -$21,509 |
| % Margin | -145.3% | -133.3% | -302.1% | -142.5% |
| EPS Diluted | -0.64 | -0.5 | -2.21 | -0.5 |
| % Growth | -28% | 77.4% | -342% | – |
| Operating Cash Flow | -$18,343 | -$26,274 | -$23,699 | -$18,384 |
| Capital Expenditures | -$7,265 | -$8,166 | -$8,044 | -$4,063 |
| Free Cash Flow | -$25,608 | -$34,440 | -$31,743 | -$22,447 |